Cholera Vaccines Market Size & Share Report, 2024 - 2032

Cholera Vaccines Market - By Product (Dukoral, Vaxchora, Euvichol/Euvichol-Plus), End-user (Public, Private) – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculations

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing incidence of cholera outbreaks.

3.2.1.2&nbsp;&nbsp;&nbsp; Growing governments support

3.2.1.3&nbsp;&nbsp;&nbsp; Expanding research funding and activities

3.2.1.4&nbsp;&nbsp;&nbsp; Growing travel to endemic regions

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Lack of access to adequate treatment

3.2.2.2&nbsp;&nbsp;&nbsp; Cold chain requirements

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Pipeline analysis

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Dukoral

5.3&nbsp;&nbsp;&nbsp; Vaxchora

5.4&nbsp;&nbsp;&nbsp; Euvichol/Euvichol-Plus

5.5&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-User, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Public

6.3&nbsp;&nbsp;&nbsp; Private

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; UK

7.3.2&nbsp;&nbsp;&nbsp; France

7.3.3&nbsp;&nbsp;&nbsp; Spain

7.3.4&nbsp;&nbsp;&nbsp; Netherlands

7.3.5&nbsp;&nbsp;&nbsp; Belgium

7.3.6&nbsp;&nbsp;&nbsp; Croatia

7.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; India

7.4.2&nbsp;&nbsp;&nbsp; Bangladesh

7.4.3&nbsp;&nbsp;&nbsp; Pakistan

7.4.4&nbsp;&nbsp;&nbsp; Philippines

7.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Columbia

7.5.2&nbsp;&nbsp;&nbsp; Peru

7.5.3&nbsp;&nbsp;&nbsp; Chile

7.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

7.6&nbsp;&nbsp;&nbsp; Middle East and Africa

7.6.1&nbsp;&nbsp;&nbsp; Syria

7.6.2&nbsp;&nbsp;&nbsp; Uganda

7.6.3&nbsp;&nbsp;&nbsp; Yemen

7.6.4&nbsp;&nbsp;&nbsp; Kenya

7.6.5&nbsp;&nbsp;&nbsp; Zimbabwe

7.6.6&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Bavarian Nordic A/S

8.2&nbsp;&nbsp;&nbsp; Bharat Biotech

8.3&nbsp;&nbsp;&nbsp; Biological E

8.4&nbsp;&nbsp;&nbsp; EuBiologics Co. Ltd.

8.5&nbsp;&nbsp;&nbsp; Hilleman Laboratories

8.6&nbsp;&nbsp;&nbsp; Incepta Pharmaceuticals Ltd.

8.7&nbsp;&nbsp;&nbsp; Shantha Biotechnics (Sanofi)

8.8&nbsp;&nbsp;&nbsp; Vabiotech

8.9&nbsp;&nbsp;&nbsp; Valneva Sweden AB 
&nbsp;

Cholera Vaccines Market

Get a free sample of this report